Chandigarh, 14 March 2025: CORONA Remedies Limited, (formerly known as CORONA Remedies Private Limited) has launched generic version of Empagliflozin introduced under the brand name “Empabite & it extensions” a SGLT-2 inhibitor, for Type 2 diabetes. With a commitment to affordability and accessibility, CORONA Remedies will offer the medication at a significantly reduced price, making […]
The post CORONA Remedies Bridges the Gap in Diabetes Care with Affordable Empagliflozin first appeared on Business News Week.